Ferrari, Gerson
Farías-Valenzuela, Claudio
Guzmán-Habinger, Juan
Drenowatz, Clemens
Marques, Adilson
Kovalskys, Irina
Gómez, Georgina
Rigotti, Attilio
Cortés, Lilia Yadira
Yépez García, Martha Cecilia
Pareja, Rossina G.
Herrera-Cuenca, Marianella
Marconcin, Priscila
Chávez, Javiera Lobos
Fisberg, Mauro
Article History
Received: 7 February 2022
Accepted: 30 March 2022
First Online: 6 April 2022
Declarations
:
: Ethical approval was provided by the Western Institutional Review Board (#20140605), and by the ethical review boards of the participating institutions. ELANS is registered at Clinical Trials #NCT02226627. This research was performed according to the ethical principles from the Declaration of Helsinki. Written informed consent/assent was obtained from all individuals, before commencement of the study.
: Not applicable.
: M.F. has received fees and consultancy payments from biotechnology, pharmaceutical and food and beverage companies. He has also received fees, payments for consulting and financing research studies without any restrictions, from government sources and non-profit entities. The rest of the authors also have no conflicts of interest to declare. None of the entities mentioned had or have any role in the design or preparation of this manuscript.